A biotin-avidin-system-based virus-mimicking nanovaccine for tumor immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A biotin-avidin-system-based virus-mimicking nanovaccine for tumor immunotherapy

Published:2021-04 Issue: Volume:332 Page:245-259
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Lu Zhuoxuan,Zhang Yanwei,Wang Yi,Tan Guang-Hong,Huang Feng-Ying,Cao Rong,He Nongyue,Zhang Liming

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Hainan Province Natural Science Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference55 articles.

1. Immune checkpoint blockade: a common denominator approach to cancer therapy;Topalian;Cancer Cell,2015

2. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial;Rizvi;Lancet Oncol.,2015

3. Immune checkpoint inhibitors: making immunotherapy a reality for the treatment of lung cancer;Brahmer;Cancer Immunol. Res.,2013

4. Immune checkpoint inhibitors: new insights and current place in cancer therapy;La-Beck;Pharmacotherapy,2015

5. Review of cancer treatment with immune checkpoint inhibitors;Thallinger;Wien. Klin. Wochenschr.,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic nanotechnology for cancer immunotherapy: State of the art and future perspective;International Journal of Pharmaceutics;2024-04

2. Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy;Exploration;2024-03-28

3. Viral Vector–Based Nanoparticles;Nanocarrier Vaccines;2024-02-16

4. Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives;Advanced NanoBiomed Research;2024-01-26

5. High-throughput quantitative detection of triple-negative breast cancer-associated expressed miRNAs by rolling circle amplification on fluorescence-encoded microspheres;Chinese Chemical Letters;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3